ATH 0.00% 0.3¢ alterity therapeutics limited

What to hopefully look forward too, page-12

  1. 5,923 Posts.
    lightbulb Created with Sketch. 151
    Hi pivalde. That was a great post. I believe those open label interim results were very positive. To see some efficacy at all in humans at this early stage is fantastic. They are the first human results after the animal models. As far as I know no other drug has demonstrated any efficacy against MSA. Most drugs fail during that step. PBT434 has crossed that step with strong evidence of efficacy in humans, with a double blind trial following close behind. The responders in the open label were all earlier stage, similar to the patients in the double blind.
    201 is still a double blind, so by no means a slam dunk yet. but the risk of failure has been substantially reduced. I have no idea why the price would ease back on that news. Price manipulation maybe?
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.4¢ 0.2¢ $36.94K 11.98M

Buyers (Bids)

No. Vol. Price($)
1 741680 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 152086887 65
View Market Depth
Last trade - 16.10pm 05/11/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.